NPPA and cardiac hypertrophy: However, as shown in Figure 8A–C, X22 treatment had a protective effect in HFD‐induced cardiac remodelling and also significantly inhibited the mRNA expression of ANP and BNP, suggesting that X22 prevents the development of cardiac hypertrophy in HFD‐fed rats.